BMN-349

N/A

Report date: 2024/04/24 17:06:07
NME

Base Information

Drug NameBMN-349
Drug Alias NameBMN-349
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1-antiproteinase modulatorsProteins folding stabilizers
TargetsAlpha-1-antiproteinase +[2] 
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical Inc
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A